Global Renal Drugs Market Growth (Status and Outlook) 2023-2029

March 2023 | 87 pages | ID: G0D0DD5FD856EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Renal diseases are becoming a significant health issue among the general population. Renal drugs are majorly used for kidney disease treatment.

LPI (LP Information)' newest research report, the “Renal Drugs Industry Forecast” looks at past sales and reviews total world Renal Drugs sales in 2022, providing a comprehensive analysis by region and market sector of projected Renal Drugs sales for 2023 through 2029. With Renal Drugs sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Renal Drugs industry.

This Insight Report provides a comprehensive analysis of the global Renal Drugs landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Renal Drugs portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Renal Drugs market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Renal Drugs and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Renal Drugs.

The global Renal Drugs market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Renal Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Renal Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Renal Drugs is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Renal Drugs players cover Mylan, Roche Holding, Endo International, Bausch Health Companies, Apotex, Cardinal Health, Fresenius and Dava Pharmaceuticals, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Renal Drugs market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Oral
• Injections

Segmentation by application

• Hospital Pharmacy
• Retail Pharmacies
• Drug Stores
• Online Pharmacy
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Mylan
• Roche Holding
• Endo International
• Bausch Health Companies
• Apotex
• Cardinal Health
• Fresenius
• Dava Pharmaceuticals

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Renal Drugs Market Size 2018-2029
  2.1.2 Renal Drugs Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Renal Drugs Segment by Type
  2.2.1 Oral
  2.2.2 Injections
2.3 Renal Drugs Market Size by Type
  2.3.1 Renal Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Renal Drugs Market Size Market Share by Type (2018-2023)
2.4 Renal Drugs Segment by Application
  2.4.1 Hospital Pharmacy
  2.4.2 Retail Pharmacies
  2.4.3 Drug Stores
  2.4.4 Online Pharmacy
  2.4.5 Others
2.5 Renal Drugs Market Size by Application
  2.5.1 Renal Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Renal Drugs Market Size Market Share by Application (2018-2023)

3 RENAL DRUGS MARKET SIZE BY PLAYER

3.1 Renal Drugs Market Size Market Share by Players
  3.1.1 Global Renal Drugs Revenue by Players (2018-2023)
  3.1.2 Global Renal Drugs Revenue Market Share by Players (2018-2023)
3.2 Global Renal Drugs Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 RENAL DRUGS BY REGIONS

4.1 Renal Drugs Market Size by Regions (2018-2023)
4.2 Americas Renal Drugs Market Size Growth (2018-2023)
4.3 APAC Renal Drugs Market Size Growth (2018-2023)
4.4 Europe Renal Drugs Market Size Growth (2018-2023)
4.5 Middle East & Africa Renal Drugs Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Renal Drugs Market Size by Country (2018-2023)
5.2 Americas Renal Drugs Market Size by Type (2018-2023)
5.3 Americas Renal Drugs Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Renal Drugs Market Size by Region (2018-2023)
6.2 APAC Renal Drugs Market Size by Type (2018-2023)
6.3 APAC Renal Drugs Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Renal Drugs by Country (2018-2023)
7.2 Europe Renal Drugs Market Size by Type (2018-2023)
7.3 Europe Renal Drugs Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Renal Drugs by Region (2018-2023)
8.2 Middle East & Africa Renal Drugs Market Size by Type (2018-2023)
8.3 Middle East & Africa Renal Drugs Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL RENAL DRUGS MARKET FORECAST

10.1 Global Renal Drugs Forecast by Regions (2024-2029)
  10.1.1 Global Renal Drugs Forecast by Regions (2024-2029)
  10.1.2 Americas Renal Drugs Forecast
  10.1.3 APAC Renal Drugs Forecast
  10.1.4 Europe Renal Drugs Forecast
  10.1.5 Middle East & Africa Renal Drugs Forecast
10.2 Americas Renal Drugs Forecast by Country (2024-2029)
  10.2.1 United States Renal Drugs Market Forecast
  10.2.2 Canada Renal Drugs Market Forecast
  10.2.3 Mexico Renal Drugs Market Forecast
  10.2.4 Brazil Renal Drugs Market Forecast
10.3 APAC Renal Drugs Forecast by Region (2024-2029)
  10.3.1 China Renal Drugs Market Forecast
  10.3.2 Japan Renal Drugs Market Forecast
  10.3.3 Korea Renal Drugs Market Forecast
  10.3.4 Southeast Asia Renal Drugs Market Forecast
  10.3.5 India Renal Drugs Market Forecast
  10.3.6 Australia Renal Drugs Market Forecast
10.4 Europe Renal Drugs Forecast by Country (2024-2029)
  10.4.1 Germany Renal Drugs Market Forecast
  10.4.2 France Renal Drugs Market Forecast
  10.4.3 UK Renal Drugs Market Forecast
  10.4.4 Italy Renal Drugs Market Forecast
  10.4.5 Russia Renal Drugs Market Forecast
10.5 Middle East & Africa Renal Drugs Forecast by Region (2024-2029)
  10.5.1 Egypt Renal Drugs Market Forecast
  10.5.2 South Africa Renal Drugs Market Forecast
  10.5.3 Israel Renal Drugs Market Forecast
  10.5.4 Turkey Renal Drugs Market Forecast
  10.5.5 GCC Countries Renal Drugs Market Forecast
10.6 Global Renal Drugs Forecast by Type (2024-2029)
10.7 Global Renal Drugs Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 Mylan
  11.1.1 Mylan Company Information
  11.1.2 Mylan Renal Drugs Product Offered
  11.1.3 Mylan Renal Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 Mylan Main Business Overview
  11.1.5 Mylan Latest Developments
11.2 Roche Holding
  11.2.1 Roche Holding Company Information
  11.2.2 Roche Holding Renal Drugs Product Offered
  11.2.3 Roche Holding Renal Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.2.4 Roche Holding Main Business Overview
  11.2.5 Roche Holding Latest Developments
11.3 Endo International
  11.3.1 Endo International Company Information
  11.3.2 Endo International Renal Drugs Product Offered
  11.3.3 Endo International Renal Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.3.4 Endo International Main Business Overview
  11.3.5 Endo International Latest Developments
11.4 Bausch Health Companies
  11.4.1 Bausch Health Companies Company Information
  11.4.2 Bausch Health Companies Renal Drugs Product Offered
  11.4.3 Bausch Health Companies Renal Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.4.4 Bausch Health Companies Main Business Overview
  11.4.5 Bausch Health Companies Latest Developments
11.5 Apotex
  11.5.1 Apotex Company Information
  11.5.2 Apotex Renal Drugs Product Offered
  11.5.3 Apotex Renal Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.5.4 Apotex Main Business Overview
  11.5.5 Apotex Latest Developments
11.6 Cardinal Health
  11.6.1 Cardinal Health Company Information
  11.6.2 Cardinal Health Renal Drugs Product Offered
  11.6.3 Cardinal Health Renal Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.6.4 Cardinal Health Main Business Overview
  11.6.5 Cardinal Health Latest Developments
11.7 Fresenius
  11.7.1 Fresenius Company Information
  11.7.2 Fresenius Renal Drugs Product Offered
  11.7.3 Fresenius Renal Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.7.4 Fresenius Main Business Overview
  11.7.5 Fresenius Latest Developments
11.8 Dava Pharmaceuticals
  11.8.1 Dava Pharmaceuticals Company Information
  11.8.2 Dava Pharmaceuticals Renal Drugs Product Offered
  11.8.3 Dava Pharmaceuticals Renal Drugs Revenue, Gross Margin and Market Share (2018-2023)
  11.8.4 Dava Pharmaceuticals Main Business Overview
  11.8.5 Dava Pharmaceuticals Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Renal Drugs Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Oral
Table 3. Major Players of Injections
Table 4. Renal Drugs Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Renal Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Renal Drugs Market Size Market Share by Type (2018-2023)
Table 7. Renal Drugs Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Renal Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Renal Drugs Market Size Market Share by Application (2018-2023)
Table 10. Global Renal Drugs Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Renal Drugs Revenue Market Share by Player (2018-2023)
Table 12. Renal Drugs Key Players Head office and Products Offered
Table 13. Renal Drugs Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Renal Drugs Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Renal Drugs Market Size Market Share by Regions (2018-2023)
Table 18. Global Renal Drugs Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Renal Drugs Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Renal Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Renal Drugs Market Size Market Share by Country (2018-2023)
Table 22. Americas Renal Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Renal Drugs Market Size Market Share by Type (2018-2023)
Table 24. Americas Renal Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Renal Drugs Market Size Market Share by Application (2018-2023)
Table 26. APAC Renal Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Renal Drugs Market Size Market Share by Region (2018-2023)
Table 28. APAC Renal Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Renal Drugs Market Size Market Share by Type (2018-2023)
Table 30. APAC Renal Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Renal Drugs Market Size Market Share by Application (2018-2023)
Table 32. Europe Renal Drugs Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Renal Drugs Market Size Market Share by Country (2018-2023)
Table 34. Europe Renal Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Renal Drugs Market Size Market Share by Type (2018-2023)
Table 36. Europe Renal Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Renal Drugs Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Renal Drugs Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Renal Drugs Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Renal Drugs Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Renal Drugs Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Renal Drugs Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Renal Drugs Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Renal Drugs
Table 45. Key Market Challenges & Risks of Renal Drugs
Table 46. Key Industry Trends of Renal Drugs
Table 47. Global Renal Drugs Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Renal Drugs Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Renal Drugs Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Renal Drugs Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. Mylan Details, Company Type, Renal Drugs Area Served and Its Competitors
Table 52. Mylan Renal Drugs Product Offered
Table 53. Mylan Renal Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. Mylan Main Business
Table 55. Mylan Latest Developments
Table 56. Roche Holding Details, Company Type, Renal Drugs Area Served and Its Competitors
Table 57. Roche Holding Renal Drugs Product Offered
Table 58. Roche Holding Main Business
Table 59. Roche Holding Renal Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 60. Roche Holding Latest Developments
Table 61. Endo International Details, Company Type, Renal Drugs Area Served and Its Competitors
Table 62. Endo International Renal Drugs Product Offered
Table 63. Endo International Main Business
Table 64. Endo International Renal Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 65. Endo International Latest Developments
Table 66. Bausch Health Companies Details, Company Type, Renal Drugs Area Served and Its Competitors
Table 67. Bausch Health Companies Renal Drugs Product Offered
Table 68. Bausch Health Companies Main Business
Table 69. Bausch Health Companies Renal Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 70. Bausch Health Companies Latest Developments
Table 71. Apotex Details, Company Type, Renal Drugs Area Served and Its Competitors
Table 72. Apotex Renal Drugs Product Offered
Table 73. Apotex Main Business
Table 74. Apotex Renal Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 75. Apotex Latest Developments
Table 76. Cardinal Health Details, Company Type, Renal Drugs Area Served and Its Competitors
Table 77. Cardinal Health Renal Drugs Product Offered
Table 78. Cardinal Health Main Business
Table 79. Cardinal Health Renal Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 80. Cardinal Health Latest Developments
Table 81. Fresenius Details, Company Type, Renal Drugs Area Served and Its Competitors
Table 82. Fresenius Renal Drugs Product Offered
Table 83. Fresenius Main Business
Table 84. Fresenius Renal Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 85. Fresenius Latest Developments
Table 86. Dava Pharmaceuticals Details, Company Type, Renal Drugs Area Served and Its Competitors
Table 87. Dava Pharmaceuticals Renal Drugs Product Offered
Table 88. Dava Pharmaceuticals Main Business
Table 89. Dava Pharmaceuticals Renal Drugs Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 90. Dava Pharmaceuticals Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Renal Drugs Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Renal Drugs Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Renal Drugs Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Renal Drugs Sales Market Share by Country/Region (2022)
Figure 8. Renal Drugs Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Renal Drugs Market Size Market Share by Type in 2022
Figure 10. Renal Drugs in Hospital Pharmacy
Figure 11. Global Renal Drugs Market: Hospital Pharmacy (2018-2023) & ($ Millions)
Figure 12. Renal Drugs in Retail Pharmacies
Figure 13. Global Renal Drugs Market: Retail Pharmacies (2018-2023) & ($ Millions)
Figure 14. Renal Drugs in Drug Stores
Figure 15. Global Renal Drugs Market: Drug Stores (2018-2023) & ($ Millions)
Figure 16. Renal Drugs in Online Pharmacy
Figure 17. Global Renal Drugs Market: Online Pharmacy (2018-2023) & ($ Millions)
Figure 18. Renal Drugs in Others
Figure 19. Global Renal Drugs Market: Others (2018-2023) & ($ Millions)
Figure 20. Global Renal Drugs Market Size Market Share by Application in 2022
Figure 21. Global Renal Drugs Revenue Market Share by Player in 2022
Figure 22. Global Renal Drugs Market Size Market Share by Regions (2018-2023)
Figure 23. Americas Renal Drugs Market Size 2018-2023 ($ Millions)
Figure 24. APAC Renal Drugs Market Size 2018-2023 ($ Millions)
Figure 25. Europe Renal Drugs Market Size 2018-2023 ($ Millions)
Figure 26. Middle East & Africa Renal Drugs Market Size 2018-2023 ($ Millions)
Figure 27. Americas Renal Drugs Value Market Share by Country in 2022
Figure 28. United States Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 29. Canada Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 30. Mexico Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 31. Brazil Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 32. APAC Renal Drugs Market Size Market Share by Region in 2022
Figure 33. APAC Renal Drugs Market Size Market Share by Type in 2022
Figure 34. APAC Renal Drugs Market Size Market Share by Application in 2022
Figure 35. China Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 36. Japan Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 37. Korea Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 38. Southeast Asia Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 39. India Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 40. Australia Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 41. Europe Renal Drugs Market Size Market Share by Country in 2022
Figure 42. Europe Renal Drugs Market Size Market Share by Type (2018-2023)
Figure 43. Europe Renal Drugs Market Size Market Share by Application (2018-2023)
Figure 44. Germany Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 45. France Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 46. UK Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 47. Italy Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 48. Russia Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 49. Middle East & Africa Renal Drugs Market Size Market Share by Region (2018-2023)
Figure 50. Middle East & Africa Renal Drugs Market Size Market Share by Type (2018-2023)
Figure 51. Middle East & Africa Renal Drugs Market Size Market Share by Application (2018-2023)
Figure 52. Egypt Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 53. South Africa Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 54. Israel Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 55. Turkey Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 56. GCC Country Renal Drugs Market Size Growth 2018-2023 ($ Millions)
Figure 57. Americas Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 58. APAC Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 59. Europe Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 60. Middle East & Africa Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 61. United States Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 62. Canada Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 63. Mexico Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 64. Brazil Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 65. China Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 66. Japan Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 67. Korea Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 68. Southeast Asia Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 69. India Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 70. Australia Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 71. Germany Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 72. France Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 73. UK Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 74. Italy Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 75. Russia Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 76. Spain Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 77. Egypt Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 78. South Africa Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 79. Israel Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 80. Turkey Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 81. GCC Countries Renal Drugs Market Size 2024-2029 ($ Millions)
Figure 82. Global Renal Drugs Market Size Market Share Forecast by Type (2024-2029)
Figure 83. Global Renal Drugs Market Size Market Share Forecast by Application (2024-2029)